Department of Pancreato-Biliary Surgery, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei, Anhui 230001, P.R. China.
Department of Hepatobiliary Surgery, Yijishan Hospital Affiliated to Wannan Medical College, Wuhu, Anhui 241001, P.R. China.
Int J Mol Med. 2018 Mar;41(3):1740-1748. doi: 10.3892/ijmm.2018.3358. Epub 2018 Jan 2.
The aim of the present study was to explore the role of miR‑493-5p in liver cancer tissues and cell lines, and its effect on cell behavioral characteristics. The expression of miR-493-5p was detected by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) in liver cancer tissues and cell lines (hepatic cell line HL-7702 and the liver cancer cell lines HCCC-9810, HuH-7 and HepG2). In addition, the mechanism by which miR-493-5p mediates its effects was analyzed via the transfection of miR-493-5p mimic and negative control miRNA into HepG2 cells. The viability, proliferation, apoptosis and invasion of the cells were analyzed using MTT assay, flow cytometry and Transwell chamber experiments. Furthermore, the effect of miR-493-5p on the expression of vesicle associated membrane protein 2 (VAMP2) was assayed using a dual-luciferase reporter system, and VAMP2 protein levels were determined by western blot analysis. In addition, following the cotransfection of HepG2 cells with pcDNA3.1‑VAMP2 plasmid and miR‑493-5p mimic, the role of miR-493-5p as a regulator of VAMP2 was evaluated using MTT assay, flow cytometry and Transwell chamber experiments. RT-qPCR analysis indicated that the expression of miR-493-5p in liver cancer tissues and cell lines was decreased significantly compared with that in adjacent normal liver tissues and normal liver cell lines, respectively. Compared with the control group, the cells transfected with miR-493-5p mimic (the miR-493-5p overexpression group) exhibited reduced cell viability, a reduced percentage of cells in the S phase and an increased percentage of apoptotic cells. In addition, fewer cells passed through the Transwell membrane in the miR-493-5p overexpression group compared with the control group. In the dual-luciferase reporter assay, luciferase activity in the miR‑493-5p overexpression group was attenuated compared with that in the control group. In addition, western blot analysis indicated that the VAMP2 protein levels in the miR‑493-5p overexpression group were lower than those in the control group. Furthermore, in cells overexpressing miR-493-5p and VAMP2 simultaneously, the biological behavior of the cells, including cell viability, cell cycle and cell invasiveness, was significantly rescued compared with that of the control group transfected with miR‑493-5p alone. In conclusion, miR-493-5p is indicated to be a tumor suppressor gene, and is downregulated in human liver cancer. miR-493-5p overexpression promotes cell apoptosis and inhibits the proliferation and migration of liver cancer cells by negatively regulating the expression of VAMP. These observations suggest the potential of treating liver cancer by the overexpression of microRNA-493-5p.
本研究旨在探讨 miR-493-5p 在肝癌组织和细胞系中的作用及其对细胞行为特征的影响。通过逆转录定量聚合酶链反应(RT-qPCR)检测肝癌组织和细胞系(肝细胞系 HL-7702 及肝癌细胞系 HCCC-9810、HuH-7 和 HepG2)中 miR-493-5p 的表达。此外,通过转染 miR-493-5p 模拟物和阴性对照 miRNA 到 HepG2 细胞中,分析 miR-493-5p 介导其作用的机制。通过 MTT 测定、流式细胞术和 Transwell 室实验分析细胞活力、增殖、凋亡和侵袭。此外,通过双荧光素酶报告系统检测 miR-493-5p 对囊泡相关膜蛋白 2(VAMP2)表达的影响,并通过 Western blot 分析检测 VAMP2 蛋白水平。此外,在共转染 HepG2 细胞 pcDNA3.1-VAMP2 质粒和 miR-493-5p 模拟物后,通过 MTT 测定、流式细胞术和 Transwell 室实验评估 miR-493-5p 作为 VAMP2 调节剂的作用。RT-qPCR 分析表明,与相邻正常肝组织和正常肝细胞系相比,肝癌组织和细胞系中 miR-493-5p 的表达明显降低。与对照组相比,转染 miR-493-5p 模拟物(miR-493-5p 过表达组)的细胞活力降低,S 期细胞比例降低,凋亡细胞比例增加。此外,miR-493-5p 过表达组穿过 Transwell 膜的细胞数量少于对照组。在双荧光素酶报告实验中,miR-493-5p 过表达组的荧光素酶活性低于对照组。此外,Western blot 分析表明,miR-493-5p 过表达组的 VAMP2 蛋白水平低于对照组。此外,在同时过表达 miR-493-5p 和 VAMP2 的细胞中,与单独转染 miR-493-5p 的对照组相比,细胞的生物学行为,包括细胞活力、细胞周期和细胞侵袭性,得到显著挽救。综上所述,miR-493-5p 被认为是一种肿瘤抑制基因,在人类肝癌中下调。miR-493-5p 的过表达通过负调控 VAMP 的表达促进细胞凋亡并抑制肝癌细胞的增殖和迁移。这些观察结果表明,通过过表达 microRNA-493-5p 可能治疗肝癌。